We have previously reported that inhibiting MCL‐1 expression with S63845 produces a synergistic apoptotic response when used in combination with venetoclax in acute myeloid leukaemia (AML) cells [13]. This evidence concerns the gene MCL1 and acute myeloid leukemia.